Isotopia Molecular Imaging and Sinotau Pharmaceuticals Sign a Clinical Supply Agreement for 177Lu n.c.a

Petach Tikva, Israel, and Beijing China 19 Oct 2021 Petach Tikva, Israel, and Beijing China 19 Oct 2021 Isotopia Molecular Imaging and Sinotau Pharmaceuticals, a global radiopharmaceutical developer and producer, are pleased to announce a strategic collaboration for the supply of the medical radioisotope non-carrier-added 177Lu to support the clinical development of Sinotau’s pipeline. The […]

Isotopia and the Peter MacCallum Cancer Center announce Terbium-161 clinical study collaboration

October 31st, 2021 – Petach Tikva, Israel and Melbourne, Australia October 31st, 2021 – Petach Tikva, Israel and Melbourne, Australia Isotopia to supply the Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) at Peter Mac with no-carrier-added Tb-161 for use in clinical research Peter MacCallum Cancer Centre, world leading cancer research, education and treatment […]

Getting to know Isotopia’s supply chain

Isotopia’s supply chain

Join us for this webinar where our own head of therapy Eyal Gimshi will talk about the journey of Lu-177 from starting material to the patient. 11:00 am EDT on July 14, 2021 The Canadian Nuclear Isotope Council (CNIC) is an independent organization consisting of representatives from various levels within the Canadian health sector, nuclear industry, and research bodies, […]